|
|
|
Insider
Information: |
Chin Richard |
Relationship: |
Director |
City: |
Waltham, |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
423,413 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$145,814 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
423,413 |
|
|
Total
Value |
$145,814 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Mateon Therapeutics Inc |
MATN |
President and CEO, Dir... |
2008-01-11 |
392,074 |
2005-08-24 |
0 |
Premium* |
|
Kindred Biosciences, Inc. |
KIN |
Chief Executive Office... |
2021-08-27 |
0 |
2021-08-27 |
0 |
Premium* |
|
SELLAS Life Sciences Group Inc |
SLS |
Director |
2017-10-10 |
31,339 |
2014-01-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
58 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
KIN |
Kindred Biosciences, Inc. |
Chief Executive Officer |
|
2021-01-22 |
4 |
D |
$4.93 |
$97,338 |
D/D |
(19,744) |
1,981,516 |
0 |
- |
|
MATN |
Mateon Therapeutics Inc |
President and CEO |
|
2006-08-01 |
4 |
B |
$3.28 |
$65,950 |
D/D |
20,000 |
60,000 |
2.81 |
- |
|
KIN |
Kindred Biosciences, Inc. |
President and CEO |
|
2018-04-02 |
4 |
AS |
$8.39 |
$167,800 |
D/D |
(20,000) |
2,266,071 |
0 |
- |
|
KIN |
Kindred Biosciences, Inc. |
President and CEO |
|
2018-05-01 |
4 |
AS |
$9.05 |
$181,000 |
D/D |
(20,000) |
2,246,071 |
0 |
- |
|
KIN |
Kindred Biosciences, Inc. |
Chief Executive Officer |
|
2021-01-17 |
4 |
D |
$4.95 |
$104,584 |
D/D |
(21,128) |
1,963,760 |
0 |
- |
|
KIN |
Kindred Biosciences, Inc. |
PRESIDENT AND CEO |
|
2018-09-04 |
4 |
AS |
$14.81 |
$479,844 |
D/D |
(32,400) |
2,073,671 |
0 |
- |
|
MATN |
Mateon Therapeutics Inc |
President and CEO |
|
2008-01-11 |
4 |
A |
$0.00 |
$0 |
D/D |
36,610 |
392,074 |
0 |
- |
|
KIN |
Kindred Biosciences, Inc. |
Chief Executive Officer |
|
2019-01-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
37,500 |
1,943,571 |
0 |
- |
|
KIN |
Kindred Biosciences, Inc. |
Chief Executive Officer |
|
2020-01-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
37,500 |
1,959,457 |
0 |
- |
|
KIN |
Kindred Biosciences, Inc. |
Chief Executive Officer |
|
2021-01-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
37,500 |
1,984,888 |
0 |
- |
|
KIN |
Kindred Biosciences, Inc. |
Chief Executive Officer |
|
2021-01-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
37,500 |
2,001,260 |
0 |
- |
|
MATN |
Mateon Therapeutics Inc |
Director |
|
2005-08-24 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
40,000 |
|
- |
|
KIN |
Kindred Biosciences, Inc. |
President and CEO |
|
2018-06-01 |
4 |
AS |
$10.13 |
$405,200 |
D/D |
(40,000) |
2,186,071 |
0 |
- |
|
KIN |
Kindred Biosciences, Inc. |
President and CEO |
|
2018-07-02 |
4 |
AS |
$10.28 |
$411,200 |
D/D |
(40,000) |
2,146,071 |
0 |
- |
|
KIN |
Kindred Biosciences, Inc. |
President and CEO |
|
2018-08-01 |
4 |
AS |
$13.51 |
$540,400 |
D/D |
(40,000) |
2,106,071 |
0 |
- |
|
KIN |
Kindred Biosciences, Inc. |
President and CEO |
|
2018-10-01 |
4 |
AS |
$13.28 |
$531,200 |
D/D |
(40,000) |
2,026,071 |
0 |
- |
|
KIN |
Kindred Biosciences, Inc. |
CEO |
|
2018-11-01 |
4 |
AS |
$14.68 |
$587,200 |
D/D |
(40,000) |
1,986,071 |
0 |
- |
|
KIN |
Kindred Biosciences, Inc. |
Chief Executive Officer |
|
2018-12-03 |
4 |
AS |
$13.28 |
$531,200 |
D/D |
(40,000) |
1,946,071 |
0 |
- |
|
KIN |
Kindred Biosciences, Inc. |
Chief Executive Officer |
|
2019-01-02 |
4 |
AS |
$10.57 |
$422,716 |
D/D |
(40,000) |
1,906,071 |
0 |
- |
|
KIN |
Kindred Biosciences, Inc. |
Chief Executive Officer |
|
2021-06-16 |
4 |
AS |
$9.18 |
$367,268 |
D/D |
(40,000) |
1,934,271 |
0 |
% |
|
KIN |
Kindred Biosciences, Inc. |
Chief Executive Officer |
|
2021-07-02 |
4 |
AS |
$9.18 |
$367,080 |
D/D |
(40,000) |
1,894,271 |
0 |
% |
|
KIN |
Kindred Biosciences, Inc. |
Chief Executive Officer |
|
2021-08-02 |
4 |
AS |
$9.21 |
$368,240 |
D/D |
(40,000) |
1,534,271 |
0 |
% |
|
MATN |
Mateon Therapeutics Inc |
President and CEO |
|
2006-09-15 |
4 |
B |
$4.02 |
$185,837 |
D/D |
45,464 |
105,464 |
2.81 |
- |
|
SLS |
SELLAS Life Sciences Grou... |
Director |
|
2014-01-30 |
4 |
OE |
$0.72 |
$57,250 |
D/D |
75,000 |
75,000 |
0 |
- |
|
SLS |
SELLAS Life Sciences Grou... |
Director |
|
2014-01-30 |
4 |
S |
$5.57 |
$418,755 |
D/D |
(75,000) |
0 |
0 |
- |
|
58 Records found
|
|
Page 2 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|